![Mitchell Chan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mitchell Chan
Direttore/Membro del Consiglio presso AVALO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Mitchell Chan is an Independent Director at Avalo Therapeutics, Inc. and a Director at Maryland Technology Council.
He was previously a Director-Investor Relations at AstraZeneca PLC and the Chief Financial & Accounting Officer at Viela Bio, Inc. He holds an MBA from Rotman School of Management and undergraduate and graduate degrees from the University of Toronto.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
AVALO THERAPEUTICS INC
-.--% | 17/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Mitchell Chan
Società | Posizione | Inizio |
---|---|---|
AVALO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2021 |
Maryland Technology Council
![]() Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services The Maryland Technology Council functions as a technology trade association. The private company is based in Rockville, MD. | Direttore/Membro del Consiglio | 11/03/2020 |
Precedenti posizioni note di Mitchell Chan
Società | Posizione | Fine |
---|---|---|
VIELA BIO, INC. | Direttore Finanziario/CFO | 15/03/2021 |
ASTRAZENECA PLC | Contatto Relazioni con gli Investitori | - |
Formazione di Mitchell Chan
Rotman School of Management | Masters Business Admin |
University of Toronto | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
AVALO THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Maryland Technology Council
![]() Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services The Maryland Technology Council functions as a technology trade association. The private company is based in Rockville, MD. | Commercial Services |
Viela Bio, Inc.
![]() Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- Mitchell Chan